5. Culturally Competent Care for Substance Users Diagnosed with HIV Disease
Comorbidity of Substance Abuse and HIV Infection
Substance use is a commonly occurring comorbid condition in individuals with HIV infection. HIV-positive substance users who receive no or inadequate treatment for their substance disorder are more likely to experience poorer outcome of their treatment for HIV disease. [Fiellin 2004, Sullivan 2004] The 4 most frequently abused substances among persons living with HIV disease are: alcohol, methamphetamines, cocaine, and opiates (including heroin). Each of these types of substances can have different negative effects on efforts both to prevent HIV transmission and to treat HIV in already infected patients.
Alcohol
Studies have reported the presence of alcohol problems or alcohol use disorders in 22% to 60% of HIV-infected patients [Phillips 2001, Petry 1999, Cook 2001] and alcohol abuse or dependence in 12% to 41% of HIV patients. [Lefevre 1995, Dew 1997].
Alcohol abuse may affect both the progression of HIV disease and its treatment:
- In vitro studies have reported enhanced HIV replication and decreased levels of certain immunomodulators with alcohol exposure. [Bagasra, 1989, Cook 1997] Alcohol abuse has been shown to be associated with reduced adherence to antiretroviral regimens [Fabris 2000, Cook 2001, Galvan 2002] and with higher plasma HIV-1 RNA levels and lower CD4+ cell counts. [Palepu 2004]
Treatment for alcohol use in patients who do not meet the criteria for alcohol abuse and dependence but who are considered at risk include brief, targeted interventions—generally in the office, focusing on the consequences of alcohol abuse (eg, potential impact on adherence and biochemical damage) and recommendations regarding appropriate and inappropriate amounts of alcohol consumption. [Wilk 1997, Fleming 1997]
Individuals who meet the criteria for alcohol abuse and dependence require more intensive treatment, such as motivational enhancement therapy, cognitive behavioral therapy, or participation in a 12-step program. With each of these approaches, the patient attends weekly individual or group counseling, and the findings from the National Institute on Alcohol Abuse and Alcoholism’s (NIAAA) Project MATCH reported that > 50% of patients receiving a variety of such treatments achieved complete or nearly complete abstinence at 12 months. [MATCH 1997]
Although several pharmacologic treatments for alcohol abuse and dependence are currently available or in clinical investigation, few data are available on their use in HIV-infected patients. Available medications include:
- Disulfiram
- Naltrexone
- Acamprosate
Drugs in clinical investigation include the neuroleptics such as topiramate and odansetron and certain selective serotonin reuptake inhibitors. [Edwards 2011]